NO20003956L - Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten - Google Patents
Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknutenInfo
- Publication number
- NO20003956L NO20003956L NO20003956A NO20003956A NO20003956L NO 20003956 L NO20003956 L NO 20003956L NO 20003956 A NO20003956 A NO 20003956A NO 20003956 A NO20003956 A NO 20003956A NO 20003956 L NO20003956 L NO 20003956L
- Authority
- NO
- Norway
- Prior art keywords
- loop
- vector containing
- adenovirus vector
- peptide epitope
- heterologous peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7394798P | 1998-02-06 | 1998-02-06 | |
US9980198P | 1998-09-10 | 1998-09-10 | |
PCT/US1999/002549 WO1999039734A1 (en) | 1998-02-06 | 1999-02-05 | Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003956D0 NO20003956D0 (no) | 2000-08-04 |
NO20003956L true NO20003956L (no) | 2000-10-05 |
Family
ID=26755086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003956A NO20003956L (no) | 1998-02-06 | 2000-08-04 | Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten |
Country Status (11)
Country | Link |
---|---|
US (1) | US7297542B2 (no) |
EP (1) | EP1053013A4 (no) |
JP (1) | JP2002507391A (no) |
KR (1) | KR20010034487A (no) |
CN (1) | CN1304316A (no) |
AU (1) | AU744252B2 (no) |
BR (1) | BR9908613A (no) |
CA (1) | CA2327545A1 (no) |
IL (1) | IL137681A0 (no) |
NO (1) | NO20003956L (no) |
WO (1) | WO1999039734A1 (no) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157266B2 (en) * | 1999-01-25 | 2007-01-02 | Brookhaven Science Associates Llc | Structure of adenovirus bound to cellular receptor car |
US6395875B1 (en) * | 1999-01-25 | 2002-05-28 | Brookhaven Science Associates Llc | Recombinant soluble adenovirus receptor |
AU783879B2 (en) * | 1999-11-25 | 2005-12-15 | Transgene S.A. | Modified adenovirus fibre and uses |
EP1272507B1 (en) | 2000-04-12 | 2005-06-29 | Amersham Health AS | Integrin binding peptide derivatives |
JP3635462B2 (ja) | 2000-05-31 | 2005-04-06 | 国立医薬品食品衛生研究所長 | アデノウイルスベクター |
CA2410665C (en) | 2000-05-31 | 2017-11-07 | University Of Saskatchewan | Modified bovine adenovirus having altered tropism |
NO20004795D0 (no) | 2000-09-26 | 2000-09-26 | Nycomed Imaging As | Peptidbaserte forbindelser |
AU2002313616A1 (en) | 2001-07-10 | 2003-01-29 | Amersham Health As | Peptide-based compounds for targeting intergin receptors |
EP1446479B1 (en) | 2001-09-29 | 2012-08-15 | Chae-Ok Yun | Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
US20060228334A1 (en) * | 2002-07-10 | 2006-10-12 | Manuel Rosa-Calatrava | Modified adenoviral fiber with ablated to cellular receptors |
US20060281090A1 (en) * | 2003-05-01 | 2006-12-14 | University Of Washington Uw Tech Transfer- Invention Licensing | Capsid-modified adenovirus vectors and methods of using the same |
US7611868B2 (en) | 2003-05-14 | 2009-11-03 | Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Recombinant modified adenovirus fiber protein |
US20070104732A1 (en) * | 2003-10-24 | 2007-05-10 | Bernard Massie | Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
WO2005072854A1 (en) | 2004-02-02 | 2005-08-11 | The University Of British Columbia | Scodaphoresis and methods and apparatus for moving and concentrating particles |
US8529744B2 (en) | 2004-02-02 | 2013-09-10 | Boreal Genomics Corp. | Enrichment of nucleic acid targets |
US10337054B2 (en) | 2004-02-02 | 2019-07-02 | Quantum-Si Incorporated | Enrichment of nucleic acid targets |
US9186685B2 (en) | 2012-01-13 | 2015-11-17 | The University Of British Columbia | Multiple arm apparatus and methods for separation of particles |
US8518228B2 (en) | 2011-05-20 | 2013-08-27 | The University Of British Columbia | Systems and methods for enhanced SCODA |
US7473418B2 (en) | 2004-03-25 | 2009-01-06 | Cell Genesys, Inc. | Pan cancer oncolytic vectors and methods of use thereof |
DE102004021584A1 (de) * | 2004-05-03 | 2005-12-01 | Stefan Kochanek | Modifizierte virale Vektorpartikel |
US7776322B2 (en) | 2004-08-16 | 2010-08-17 | Stefan Kochanek | Modified viral vector particles |
CA2496294A1 (en) | 2005-02-07 | 2006-08-07 | The University Of British Columbia | Apparatus and methods for concentrating and separating particles such as molecules |
JP6092497B2 (ja) | 2006-03-30 | 2017-03-08 | ユニバーシティー オブ カリフォルニア | 抗ctla−4抗体の限局性分泌のための方法および組成物 |
US7919079B2 (en) | 2006-03-31 | 2011-04-05 | Biosante Pharmaceuticals, Inc. | Cancer immunotherapy compositions and methods of use |
US20100272753A1 (en) * | 2006-10-26 | 2010-10-28 | The Johns Hopkins University | Recombinant Adenovirus Vaccines |
CA2713313A1 (en) | 2008-02-01 | 2009-08-06 | The University Of British Columbia | Methods and apparatus for particle introduction and recovery |
US8791239B2 (en) * | 2008-05-04 | 2014-07-29 | University Of Maryland, College Park | Fibrous assemblies for antibody presentation, and multiplexed antigenic analysis using same |
WO2010075058A1 (en) | 2008-12-23 | 2010-07-01 | Ge Healthcare Limited | Application of 99mtc peptide-based compound as a bone marrow imaging agent |
US8877028B2 (en) | 2009-04-21 | 2014-11-04 | The University Of British Columbia | System and methods for detection of particles |
ES2385251B1 (es) | 2009-05-06 | 2013-05-06 | Fundació Privada Institut D'investigació Biomèdica De Bellvitge | Adenovirus oncolíticos para el tratamiento del cáncer. |
US9458473B2 (en) * | 2010-06-29 | 2016-10-04 | The Johns Hopkins University | Compositions and methods for retargeting virus constructs |
WO2013090806A2 (en) * | 2011-12-15 | 2013-06-20 | Washington University | Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection |
CA2867129C (en) * | 2012-03-13 | 2023-11-21 | Salk Institute For Biological Studies | Selective cell targeting using adenovirus and chemical dimers |
WO2013166444A2 (en) | 2012-05-04 | 2013-11-07 | Boreal Genomics Corp. | Biomarker analysis using scodaphoresis |
EP2971008B1 (en) | 2013-03-14 | 2018-07-25 | Salk Institute for Biological Studies | Oncolytic adenovirus compositions |
US9340835B2 (en) | 2013-03-15 | 2016-05-17 | Boreal Genomics Corp. | Method for separating homoduplexed and heteroduplexed nucleic acids |
CN104634978A (zh) * | 2013-11-13 | 2015-05-20 | 长春百克生物科技股份公司 | 一种分型检测腺病毒中和抗体的方法以及用于分型检测腺病毒中和抗体的试剂盒 |
CA2959130A1 (en) * | 2014-08-11 | 2016-02-18 | The Board Of Regents Of The University Of Texas System | Prevention of muscular dystrophy by crispr/cas9-mediated gene editing |
WO2016185284A1 (en) | 2015-05-20 | 2016-11-24 | Boreal Genomics, Inc. | Method for isolating target nucleic acid using heteroduplex binding proteins |
KR102471633B1 (ko) | 2016-02-23 | 2022-11-25 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 바이러스 동역학에 미치는 영향 최소화를 위한 치료용 아데노바이러스의 외인성 유전자 발현 |
WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
CN110062630A (zh) | 2016-12-12 | 2019-07-26 | 萨克生物研究学院 | 肿瘤靶向合成腺病毒及其用途 |
AU2017379835A1 (en) | 2016-12-21 | 2019-07-11 | Dnatrix | Armed replication-competent oncolytic adenoviruses |
EP3645551B1 (en) | 2017-06-27 | 2024-03-13 | Regeneron Pharmaceuticals, Inc. | Tropism-modified recombinant viral vectors and uses thereof for the targeted introduction of genetic material into human cells |
WO2020172509A1 (en) | 2019-02-21 | 2020-08-27 | Unleash Immuno Oncolytics, Inc. | Oncolytic adenoviral vector and methods of use |
CA3159566A1 (en) | 2019-10-29 | 2021-05-06 | Quantum-Si Incorporated | Peristaltic pumping of fluids and associated methods, systems, and devices |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
US5770442A (en) * | 1995-02-21 | 1998-06-23 | Cornell Research Foundation, Inc. | Chimeric adenoviral fiber protein and methods of using same |
EP0866721A4 (en) * | 1995-12-08 | 2003-06-04 | Univ Alabama Birmingham Res Fo | ADENOVIRAL TARGET VECTORS |
US6824771B1 (en) * | 1999-05-12 | 2004-11-30 | The Uab Research Foundation | Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
-
1999
- 1999-02-05 WO PCT/US1999/002549 patent/WO1999039734A1/en not_active Application Discontinuation
- 1999-02-05 KR KR1020007008593A patent/KR20010034487A/ko not_active Application Discontinuation
- 1999-02-05 CN CN99804659A patent/CN1304316A/zh active Pending
- 1999-02-05 EP EP99906761A patent/EP1053013A4/en not_active Withdrawn
- 1999-02-05 JP JP2000530231A patent/JP2002507391A/ja active Pending
- 1999-02-05 BR BR9908613-1A patent/BR9908613A/pt not_active IP Right Cessation
- 1999-02-05 CA CA002327545A patent/CA2327545A1/en not_active Abandoned
- 1999-02-05 IL IL13768199A patent/IL137681A0/xx unknown
- 1999-02-05 AU AU26595/99A patent/AU744252B2/en not_active Ceased
- 1999-02-05 US US09/245,603 patent/US7297542B2/en not_active Expired - Fee Related
-
2000
- 2000-08-04 NO NO20003956A patent/NO20003956L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2659599A (en) | 1999-08-23 |
WO1999039734A1 (en) | 1999-08-12 |
IL137681A0 (en) | 2001-10-31 |
KR20010034487A (ko) | 2001-04-25 |
NO20003956D0 (no) | 2000-08-04 |
EP1053013A1 (en) | 2000-11-22 |
BR9908613A (pt) | 2000-10-31 |
AU744252B2 (en) | 2002-02-21 |
CN1304316A (zh) | 2001-07-18 |
CA2327545A1 (en) | 1999-08-12 |
US20020081280A1 (en) | 2002-06-27 |
JP2002507391A (ja) | 2002-03-12 |
EP1053013A4 (en) | 2004-12-22 |
US7297542B2 (en) | 2007-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003956L (no) | Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten | |
NO20011747D0 (no) | Stabilisert sjampo som inneholder siloksysilikat | |
DE69422632T2 (de) | Antigen enthaltende nicht-ionische Tensid Vesikel | |
DE69833503D1 (de) | Mechanismus der unterbrechung von bestimmungsortredirektion ausführt | |
FI930836A0 (fi) | Topiska preparat som innehaoller cyklosporin | |
DE69835976D1 (de) | Polarisationsunabhängiger optischer Phasenmodulator | |
FI924982A0 (fi) | Frystorkat preparat som innehaoller monoklonal motkropp | |
NO963617D0 (no) | Gassfylte mikrokapsler til bruk som kontrastmidler | |
NO20006056L (no) | Optiske fiberbånd som inneholder strålingsherdede innkapslingsmaterialer | |
DK12893D0 (da) | Fremgangsmaade til fremstilling af normal saavel som ultrafin cement | |
ID20789A (id) | Zat pemutih fluoresen | |
DK0813876T3 (da) | Cyclosporinholdigt præparat i form af en blød kapsel | |
FI925246A0 (fi) | Fluorerade aldoketendimerer och deras anvaendning som kombinerade olje och vatten resistenta lim foer cellulosa material | |
DK1109450T3 (da) | Mikrokapselpræparater | |
DK0940712T3 (da) | Projektionsskræm | |
ID23159A (id) | Wafer dan pembuatannya | |
FI933022A0 (fi) | Radiosystem som bildar en traodloes lokalslinga | |
DE29722658U1 (de) | Eine vor Bruch schützende Verpackung für mit Wafern bestückte Waferboxen | |
DE69817897D1 (de) | Phasenregelkreis | |
FR2767634B1 (fr) | Godet desileur | |
ZA200003905B (en) | Adenovirus Vector containing A Heterologous Peptide Epitope in the HI Loop of the Fiber Knob. | |
NO984307D0 (no) | Anvendelsen av spesielle tilberedninger som avskummere | |
DE29610760U1 (de) | Eimer-Container | |
FI973491A0 (fi) | Markeringsmaolning och distributionsfoerpackning som anvaender en laogtrycksbehaollare foer densamma | |
FI963615A (fi) | Peptidit, jotka estävät pepsiinin vapautumisen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |